Skip to main content
Quest Diagnostics

Frequency of Pathogenic and Likely Pathogenic Variants in Breast and Ovarian Cancer Genes Identified in a 34-Gene Hereditary Multi-Cancer Panel at a Diagnostic Reference Laboratory

BRCA 2021 Symposium: The 8th International Symposium on Hereditary Breast and Ovarian Cancer
Virtual [in-person conference canceled], May 4 - 7, 2021

Frequency of Pathogenic and Likely Pathogenic Variants in Breast and Ovarian Cancer Genes Identified in a 34-Gene Hereditary Multi-Cancer Panel at a Diagnostic Reference Laboratory
Authors: Nakles-Taylor R, Rosenthal SH, Smolgovsky A, Tully DM, Tirch J, Rhodes CH, Martz J, Hodko D, Tsao D, Nery C, Karbassi I, Grupe A, Owen R, Buller-Burckle A, Lacbawan F

Specialties: Genetics, Oncology

Download key summary

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.